Experimental drug duo targets tough thyroid cancers
NCT ID NCT07068542
Summary
This study is testing whether a new two-drug combination can help people with advanced thyroid cancer that has stopped responding to standard treatments. The trial will enroll 94 adults with specific types of aggressive thyroid cancer. Researchers will give different drug combinations based on cancer type to see if they can slow cancer growth and extend survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POORLY DIFFERENTIATED THYROID CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhejiang Provincial People's Hospital
RECRUITINGHangzhou, Zhejiang, 310014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.